Synexus Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synexus Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5140
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical trials, patient retention and others. Its therapeutic expertise spans across areas including CNS, allergy symptoms, asthma, copd, smoking cessation, sinusitis, obesity, endocrine disorders, cardiovascular, gout, osteoarthritis, osteopenia, osteoporosis, rheumatoid arthritis, dermatology, type I diabetes, diabetic foot ulcers and screenable medical conditions. Synexus undertakes clinical trials from phase II to IV. It has presence in Poland, Hungary, Ukraine, Germany, Romania, Bulgaria, South Africa and the US. Synexus is headquartered in Chorley, Lancashire, the UK.

Synexus Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synexus Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synexus Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synexus Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Synexus Acquires Clinical Trial Site 10
Private Equity 11
LDC Acquires Synexus in Management Buy-Out Transaction for USD127.7 Million 11
Acquisition 12
LDC Divests Synexus Clinical Research for USD258 Million 12
Synexus Acquires Research Across America 13
Synexus Acquires Centrum Medyczne Osteomed, Clinical Research Company 14
Synexus Ltd – Key Competitors 15
Synexus Ltd – Key Employees 16
Synexus Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 20
Other Significant Developments 20
Jun 27, 2018: Acurian and Synexus Launch SynexusPlus Enrollment-Enhanced Site Solution 20
Apr 23, 2018: Acurian and Synexus Launch NASH Patient Enrollment Solution 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Synexus Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synexus Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synexus Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Synexus Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synexus Acquires Clinical Trial Site 10
LDC Acquires Synexus in Management Buy-Out Transaction for USD127.7 Million 11
LDC Divests Synexus Clinical Research for USD258 Million 12
Synexus Acquires Research Across America 13
Synexus Acquires Centrum Medyczne Osteomed, Clinical Research Company 14
Synexus Ltd, Key Competitors 15
Synexus Ltd, Key Employees 16
Synexus Ltd, Other Locations 17
Synexus Ltd, Subsidiaries 18

List of Figures
Synexus Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synexus Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synexus Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synexus Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • First Majestic Silver Corp:企業の戦略・SWOT・財務情報
    First Majestic Silver Corp - Strategy, SWOT and Corporate Finance Report Summary First Majestic Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Airest S.p.A.:企業の戦略・SWOT・財務分析
    Airest S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Airest S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • IDL Biotech AB (IDL B):企業の財務・戦略的SWOT分析
    Summary IDL Biotech AB (IDL Biotech) is a biotechnology company that develops, manufactures and markets vitro diagnostic tests. The company offers products in the clinical areas of oncology and bacteriology. It offers vitro diagnostic tumor activity markers for common types of cancer which include b …
  • Sam’s West Inc:企業の戦略的SWOT分析
    Sam's West Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Sanofi (SAN):企業の財務・戦略的SWOT分析
    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Takaful Emarat – Insurnace (P.S.C):企業の戦略・SWOT・財務情報
    Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report Summary Takaful Emarat - Insurnace (P.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • CITGO Petroleum Corporation:企業の戦略・SWOT・財務情報
    CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Selex Gruppo Commerciale S.p.A.:戦略・SWOT・企業財務分析
    Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Fidia farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint he …
  • Societe Des Bains De Mer Sa:企業の戦略・SWOT・財務分析
    Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report Summary Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Itochu Chemical Frontier Corp-製薬・医療分野:企業M&A・提携分析
    Summary Itochu Chemical Frontier Corp (ICF), formerly Ando Kaseihin KK, a subsidiary of Itochu Corporation, is a chemical company that manufactures and markets chemical products. The company operates in intermediate chemical division, silicone and adhesive division, osaka and nagoya division, perfor …
  • AmerisourceBergen Corporation:企業の戦略・SWOT・財務情報
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Boryung Medience Corp:企業の戦略・SWOT・財務分析
    Boryung Medience Corp - Strategy, SWOT and Corporate Finance Report Summary Boryung Medience Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FMC Corporation:企業の戦略・SWOT・財務情報
    FMC Corporation - Strategy, SWOT and Corporate Finance Report Summary FMC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lead Discovery Center GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Lead Discovery Center GmbH (LDC), a subsidiary of Max Planck Innovation GmbH is a biomedical research company that offers development of novel drugs and therapies. The company develops drugs and therapies for diseases such as neurodegenerative cardiovascular diseases, cancer, inflammatory di …
  • maxingvest ag:企業の戦略・SWOT・財務分析
    maxingvest ag - Strategy, SWOT and Corporate Finance Report Summary maxingvest ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Punjab National Bank (PNB):企業の財務・戦略的SWOT分析
    Punjab National Bank (PNB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pental Limited (PTL):企業の財務・戦略的SWOT分析
    Pental Limited (PTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆